P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the merck Ad-5 multi-clade HIV vaccine

M. Latka; G. Grey; K. Fielding; L. Bekker; K. Mlisana; M. Nchabeleng; G. DeBruin; M. Allen; J. Kublin; G. Churchyard

doi:10.1186/1742-4690-6-S3-P187

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the merck Ad-5 multi-clade HIV vaccine

M. Latka^*, G. Grey, K. Fielding, L. Bekker, K. Mlisana, M. Nchabeleng, G. DeBruin, M. Allen, J. Kublin, G. Churchyard

^*Corresponding author for this work

Microbiological Pathology

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	1742
Pages (from-to)	P187
Journal	Retrovirology
Volume	6
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1186/1742-4690-6-S3-P187
Publication status	Published - 22 Oct 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/1742-4690-6-S3-P187

Cite this

Latka, M., Grey, G., Fielding, K., Bekker, L., Mlisana, K., Nchabeleng, M., DeBruin, G., Allen, M., Kublin, J., & Churchyard, G. (2009). P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the merck Ad-5 multi-clade HIV vaccine. Retrovirology, 6(SUPPL. 3), P187. Article 1742. https://doi.org/10.1186/1742-4690-6-S3-P187

@article{2dcd7bbd230b4e338c060d2bccd7ac9e,

title = "P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the merck Ad-5 multi-clade HIV vaccine",

author = "M. Latka and G. Grey and K. Fielding and L. Bekker and K. Mlisana and M. Nchabeleng and G. DeBruin and M. Allen and J. Kublin and G. Churchyard",

year = "2009",

month = oct,

day = "22",

doi = "10.1186/1742-4690-6-S3-P187",

language = "English",

volume = "6",

pages = "P187",

journal = "Retrovirology",

issn = "1742-4690",

publisher = "BioMed Central Ltd.",

number = "SUPPL. 3",

}

TY - JOUR

T1 - P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the merck Ad-5 multi-clade HIV vaccine

AU - Latka, M.

AU - Grey, G.

AU - Fielding, K.

AU - Bekker, L.

AU - Mlisana, K.

AU - Nchabeleng, M.

AU - DeBruin, G.

AU - Allen, M.

AU - Kublin, J.

AU - Churchyard, G.

PY - 2009/10/22

Y1 - 2009/10/22

UR - https://www.scopus.com/pages/publications/70449725091

U2 - 10.1186/1742-4690-6-S3-P187

DO - 10.1186/1742-4690-6-S3-P187

M3 - Comment/debate

AN - SCOPUS:70449725091

SN - 1742-4690

VL - 6

SP - P187

JO - Retrovirology

JF - Retrovirology

IS - SUPPL. 3

M1 - 1742

ER -

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the merck Ad-5 multi-clade HIV vaccine

UN SDGs

Access to Document

Other files and links

Cite this